BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17111389)

  • 1. Management of patients with resectable stage IIIA (N2) NSCLC.
    Azzoli CG
    J Surg Oncol; 2006 Dec; 94(7):551-2. PubMed ID: 17111389
    [No Abstract]   [Full Text] [Related]  

  • 2. [Our experience with patients operated after neoadjuvant therapy].
    Juhász M; Egri G; Váradi C; Mészáros Z; Keszler P
    Magy Seb; 2004 Dec; 57(6):332-5. PubMed ID: 15803876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
    J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is pneumonectomy justified in patients with locally advanced NSCLC and persistent N2 disease after induction chemotherapy?
    Klomp HM; Kappers I
    Ann Thorac Surg; 2009 Mar; 87(3):990-1. PubMed ID: 19231456
    [No Abstract]   [Full Text] [Related]  

  • 5. Surgical management of non-small cell lung cancer with mediastinal lymphadenopathy.
    Rocco G; Perrone F; Rossi A; Gridelli C
    Clin Oncol (R Coll Radiol); 2010 Jun; 22(5):325-33. PubMed ID: 20156672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.
    Johnson DH; Rusch VW; Turrisi AT
    J Natl Cancer Inst; 2007 Mar; 99(6):415-8. PubMed ID: 17374824
    [No Abstract]   [Full Text] [Related]  

  • 7. [On ''Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma: what is the answer?''].
    González Aragoneses F
    Arch Bronconeumol; 2007 Mar; 43(3):183-4; author reply 184. PubMed ID: 17386198
    [No Abstract]   [Full Text] [Related]  

  • 8. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
    Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
    Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L
    J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
    [No Abstract]   [Full Text] [Related]  

  • 10. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
    van Meerbeeck JP; Surmont VF
    Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
    Kim AW; Faber LP; Warren WH; Basu S; Wightman SC; Weber JA; Bonomi P; Liptay MJ
    Ann Thorac Surg; 2009 Sep; 88(3):937-43; discussion 944. PubMed ID: 19699924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional pulmonary resections after pneumonectomy: actual long-term survival and functional results.
    Grodzki T; Alchimowicz J; Kozak A; Kubisa B; Pieróg J; Wójcik J; Bielewicz M; Witkowska D
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):493-8. PubMed ID: 18583143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal trends in the management of potentially resectable lung cancer.
    Farjah F; Wood DE; Yanez D; Symons RG; Krishnadasan B; Flum DR
    Ann Thorac Surg; 2008 Jun; 85(6):1850-5; discussion 1856. PubMed ID: 18498783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invited commentary.
    Hoffmann H
    Ann Thorac Surg; 2009 Dec; 88(6):1736. PubMed ID: 19932226
    [No Abstract]   [Full Text] [Related]  

  • 15. [A clinical and prognostic retrospective analysis of IIIA-N2 non-small cell lung cancer].
    Zhang LM; Liu XZ; Zhang ZF; Wang CL; Zhu JQ; Yue DS
    Zhonghua Wai Ke Za Zhi; 2010 May; 48(9):690-3. PubMed ID: 20646553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invited commentary.
    Goldberg M
    Ann Thorac Surg; 2006 Jan; 81(1):304. PubMed ID: 16368386
    [No Abstract]   [Full Text] [Related]  

  • 17. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ; Han F; Gao SL; A DL; Pang ZL
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early stages of non small cell lung cancer (I. II. IIIA). What is the best therapeutic strategy?].
    Riquet M; Berna P
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S36-16S42. PubMed ID: 17268334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative chemotherapy in early-stage (stage IB-IIIA) resectable non small cell lung cancer. Is it justified?
    Prokakis Ch; Koletsis EN; Apostolakis E; Chatzimichalis A; Dougenis D
    J BUON; 2008; 13(2):161-8. PubMed ID: 18555460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Early stages of non small cell lung cancer (I. II. IIIA). Postoperative treatments for resected non small-cell lung cancer].
    Barlési F
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S47-16S53. PubMed ID: 17268336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.